LNK 754
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for LNK 754, covering 2009-09-10 to 2011-03-15. Get the full timeline:
Most recent: Clinical Trial Update: An Escalating Dose Study to Evaluate the Safety, Tolerability and Pharmacokinetics of LNK 754 in Elderly Volunteers and in Subjects With Mild Alzheimer's Disease [Phase 1]